The challenge:
A client at a large animal health company was characterizing a biologic medicine. During the characterization process, they had encountered detection limitations with commercially available lectins and wanted to further validate their mass spectrometry data and characterize the glycosylation of their drug candidate. Compounding the issue were tight deadlines and limited manpower.
Our solution:
During a productive consultation, Lectenz Bio designed a set of experiments using our proprietary SiaFind™ and SiaRich™ products. Because of time and expertise limitations, the client contracted us to perform their experiments and data analysis, taking advantage of our decades of glycoscience expertise.
The result:
The client was delighted when Lectenz Bio provided the client with a full characterization of their candidate using our reagents, beating the original deadline from the client. Along the way, we discovered several new facts about their biologic and suggested additional experiments for further validation.